SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kaji M, Ishikura H, Kishimoto T, Omi M, Ishizu A, Kimura C, et al. E-selectin expression induced by pancreas-carcinoma-derived interleukin-1 alpha results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells. Int J Cancer 1995; 60: 7127.
  • 2
    Tsuyuoka R, Takahashi T, Sasaki Y, Taniguchi Y, Fukumoto M, Suzuki A, et al. Colony-stimulating factor-producing tumours: production of granulocyte colony-stimulating factor and interleukin-6 is secondary to interleukin-1 production. Eur J Cancer 1994; 30A: 21306.
  • 3
    Li BY, Mohanraj D, Olson MC, Moradi M, Twiggs L, Carson LF, et al. Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes. Cancer Res 1992; 52: 224852.
  • 4
    Ito R, Kitadai Y, Kyo E, Yokozaki H, Yasui W, Yamashita U, et al. Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells. Cancer Res 1993; 53: 41026.
  • 5
    Anasagasti MJ, Olaso E, Calvo F, Mendoza L, Martin JJ, Bidaurrazaga J, et al. Interleukin 1-dependent and -independent mouse melanoma metastases. J Natl Cancer Inst 1997; 89: 64551.
  • 6
    Takeda K, Fujii N, Nitta Y, Sakihara H, Nakayama K, Rikiishi H, et al. Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6. Jpn J Cancer Res 1991; 82: 1299308.
  • 7
    Lafrenie RM, Gallo S, Podor TJ, Buchanan MR, Orr FW. The relative roles of vitronectin receptor, E-selectin and alpha 4 beta 1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur J Cancer 1994; 30A: 21518.
  • 8
    Lauri D, Needham L, Martin-Padura I, Dejana E. Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. J Natl Cancer Inst 1991; 83: 13214.
  • 9
    Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, et al. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 1992; 12: 16884.
  • 10
    Tran-Thang C, Kruithof E, Lahm H, Schuster WA, Tada M, Sordat B. Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Br J Cancer 1996; 74: 84652.
  • 11
    Furuya Y, Ichikura T, Mochizuki H. Interleukin-1 alpha concentration in tumors as a risk factor for liver metastasis in gastric cancer. Surg Today 1999;29: 2889.
  • 12
    Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 1st English ed. Tokyo: Kanehara, 1995.
  • 13
    SobinLH, WittekindCh, editors. UICC TNM classification of malignant tumours.5th ed. New York: John Wiley and Sons, Inc., 1997.
  • 14
    Takeshita K, Habu H, Sunagawa M, Saitoh N, Satoh Y, Endoh M. Clinico-pathological study on recurrent gastric cancer after curative resection. Nippon Geka Gakkai Zasshi 1988; 89: 17380
  • 15
    Zeki K, Morimoto I, Arao T, Eto S, Yamashita U. Interleukin-1α regulates G1 cell cycle progression and arrest in thyroid carcinoma cell lines NIM1 and NPA. J Endocrinol 1999; 160: 6773.
  • 16
    Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095147.
  • 17
    Platanias LC, Vogelzang NJ. Interleukin-1: biology, pathophysiology, and clinical prospects. Am J Med 1990; 89: 6219.
  • 18
    Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983; 49: 63649.
  • 19
    Lafrenie RM, Podor TJ, Buchanan MR, Orr FW. Up-regulated biosynthesis and expression of endothelial cell vitronectin receptor enhances cancer cell adhesion. Cancer Res 1992; 52: 22028.
  • 20
    Giavazzi R, Foppolo M, Dossi R, Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 1993; 92: 303844.
  • 21
    Takebayashi Y, Yamada K, Ohmoto Y, Sameshima T, Miyadera K, Yamada Y, et al. The correlation of thymidine phosphorylase activity with the expression of interleukin 1 alpha, interferon alpha and interferon gamma in human colorectal carcinoma. Cancer Lett 1995; 95: 5762.
  • 22
    Kimura T, Kobayashi T, Nakaya Y, Iida T, Uchimura M, Murohisa B, et al. Effect of 5′-deoxy-5-fluorouridine (5′-DFUR) on the activity of pyrimidine nucleoside phosphorylase (PyNPase) in normal and tumor tissues of human stomach. Jpn J Cancer Chemother 1995; 22: 10516.
  • 23
    Kimura O, Yurugi E, Okamoto T, Nishidoi H, Takebayashi M, Tamura H, et al. A histopathological study of gastric cancer with liver metastasis, with special reference to poorly differentiated adenocarcinoma of the medullary type. Gan No Rinsho 1984; 30: 1317
  • 24
    Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268: 904954.
  • 25
    Elias JA. Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via prostaglandin-dependent and independent mechanisms. Am Rev Respir Dis 1988; 138: 6528.
  • 26
    Goldstein RH, Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem 1982; 257: 86303.
  • 27
    Maehara Y, Moriguchi S, Kakeji Y, Kohnoe S, Korenaga D, Haraguchi M, et al. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991; 110: 8203.